首页 > 最新文献

Im Fokus Onkologie最新文献

英文 中文
Einfacher Fragebogen erleichtert geriatrisches Assessment 简易问卷有助于老年病学评估
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3733-5
T. Müller
{"title":"Einfacher Fragebogen erleichtert geriatrisches Assessment","authors":"T. Müller","doi":"10.1007/s15015-024-3733-5","DOIUrl":"https://doi.org/10.1007/s15015-024-3733-5","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"21 6","pages":"23"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DLBCL: „Immune priming“ mit Avelumab und Rituximab vor Beginn der R-CHOP-Therapie DLBCL：在开始 R-CHOP 治疗前使用阿维列单抗和利妥昔单抗进行 "免疫初始化"
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3714-0
B. Schalhorn
{"title":"DLBCL: „Immune priming“ mit Avelumab und Rituximab vor Beginn der R-CHOP-Therapie","authors":"B. Schalhorn","doi":"10.1007/s15015-023-3714-0","DOIUrl":"https://doi.org/10.1007/s15015-023-3714-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"22 8","pages":"58"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ösophaguskarzinom nach Radiochemotherapie zeitnah operieren 放化疗后及时手术治疗食道癌
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3718-9
D. Kraus
{"title":"Ösophaguskarzinom nach Radiochemotherapie zeitnah operieren","authors":"D. Kraus","doi":"10.1007/s15015-023-3718-9","DOIUrl":"https://doi.org/10.1007/s15015-023-3718-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"27 3","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nach Hochdosis-Carboplatin: Veranlassen Sie einen Hörtest! 大剂量卡铂后：安排听力测试！
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3704-2
N. Zink
{"title":"Nach Hochdosis-Carboplatin: Veranlassen Sie einen Hörtest!","authors":"N. Zink","doi":"10.1007/s15015-023-3704-2","DOIUrl":"https://doi.org/10.1007/s15015-023-3704-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"41 10","pages":"22"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139688087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verschreiben Sie Ihren Patientinnen und Patienten digitale Gesundheitsanwendungen? 您会给患者开数字健康应用处方吗？
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3754-0
Redaktion Facharztmagazine
{"title":"Verschreiben Sie Ihren Patientinnen und Patienten digitale Gesundheitsanwendungen?","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3754-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3754-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"70 5","pages":"44"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139684975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
r/r MM: Langzeitdaten zur Anti-CD38-Therapie mit Isatuximab r/r型MM：伊沙妥昔单抗抗CD38疗法的长期数据
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3703-3
J. Neumaier
{"title":"r/r MM: Langzeitdaten zur Anti-CD38-Therapie mit Isatuximab","authors":"J. Neumaier","doi":"10.1007/s15015-023-3703-3","DOIUrl":"https://doi.org/10.1007/s15015-023-3703-3","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"2 3","pages":"56"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Durchfall beim Säugling: War der Checkpointinhibitor der Mutter schuld? 婴儿腹泻：母亲服用的检查点抑制剂是罪魁祸首吗？
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3705-1
E. Oberhofer
{"title":"Durchfall beim Säugling: War der Checkpointinhibitor der Mutter schuld?","authors":"E. Oberhofer","doi":"10.1007/s15015-023-3705-1","DOIUrl":"https://doi.org/10.1007/s15015-023-3705-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"40 9","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139686877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mit Telemedizin die Dyspnoe-Inaktivitäts-Spirale nach Lungenkrebs durchbrechen 利用远程医疗打破肺癌术后呼吸困难-活动障碍的恶性循环
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3738-0
Marie-Thérèse Weitzl
{"title":"Mit Telemedizin die Dyspnoe-Inaktivitäts-Spirale nach Lungenkrebs durchbrechen","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15015-024-3738-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3738-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"58 10","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gute Ergebnisse für chemofreie Erhaltungstherapie beim TNBC TNBC 免化疗维持疗法效果良好
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3724-6
Katharina Arnheim
{"title":"Gute Ergebnisse für chemofreie Erhaltungstherapie beim TNBC","authors":"Katharina Arnheim","doi":"10.1007/s15015-024-3724-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3724-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"48 9","pages":"30"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vierfachtherapie bald Standard beim neu diagnostizierten multiplen Myelom? 四联疗法即将成为新诊断多发性骨髓瘤的标准疗法？
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3730-8
F. Klein
{"title":"Vierfachtherapie bald Standard beim neu diagnostizierten multiplen Myelom?","authors":"F. Klein","doi":"10.1007/s15015-024-3730-8","DOIUrl":"https://doi.org/10.1007/s15015-024-3730-8","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"44 23","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Im Fokus Onkologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1